Cargando…

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer

PURPOSE: To compare Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in patients with endometrial cancer receiving adjuvant pelvic radiation therapy with proton beam therapy (PT) versus intensity-modulated radiation therapy (IMRT). MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Justin D., Voss, Molly M., Laughlin, Brady S., Garda, Allison E., Aziz, Khaled, Mullikin, Trey C., Haddock, Michael G., Petersen, Ivy A., DeWees, Todd A., Vora, Sujay A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875825/ https://www.ncbi.nlm.nih.gov/pubmed/36721479 http://dx.doi.org/10.14338/IJPT-22-00020.1

Ejemplares similares

Early Experience Using Proton Beam Therapy for Extremity Soft Tissue Sarcoma: A Multicenter Study
por: Laughlin, Brady S., et al.
Publicado: (2022)

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience
por: Bhangoo, Ronik S., et al.
Publicado: (2021)

Dosimetric advantages of proton beam therapy compared to intensity-modulated radiation therapy for retroperitoneal chordoma
por: Yu, Nathan Y, et al.
Publicado: (2019)

Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer
por: Bhangoo, Ronik S., et al.
Publicado: (2021)

Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy
por: Bulman, Gabriella F., et al.
Publicado: (2021)

Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003
por: Laughlin, Brady S., et al.
Publicado: (2022)

Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience
por: Bhangoo, Ronik S., et al.
Publicado: (2020)

Intensity-Modulated Proton Therapy (IMPT) Treatment of Angiosarcoma of the Face and Scalp
por: Hunzeker, Ashley, et al.
Publicado: (2021)

Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery
por: Thorpe, Cameron S., et al.
Publicado: (2022)

Study of linear energy transfer effect on rib fracture in breast patients receiving pencil-beamscanning proton therapy
por: Yang, Yunze, et al.
Publicado: (2023)

Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy
por: Laughlin, Brady S., et al.
Publicado: (2022)

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021)

A method for quantitative evaluations of scanning‐proton dose distributions
por: Allred, Bryce C., et al.
Publicado: (2021)

Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience
por: Cosper, Pippa F., et al.
Publicado: (2017)

Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design
por: Hoppe, Bradford S., et al.
Publicado: (2023)

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
por: Laughlin, Brady S., et al.
Publicado: (2022)

Understanding American Indian Perceptions Toward Radiation Therapy
por: Patel, Samir H., et al.
Publicado: (2020)

The clinical case for proton beam therapy
por: Foote, Robert L, et al.
Publicado: (2012)

Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells
por: Thotala, Dinesh, et al.
Publicado: (2015)

Advantages of intensity modulated proton therapy during hippocampal avoidance whole brain radiation therapy
por: Stoker, Joshua, et al.
Publicado: (2018)

Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease Mapping
por: Zahrieh, David, et al.
Publicado: (2021)

Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience
por: Yu, Nathan Y., et al.
Publicado: (2019)

Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: Treatment technique and outcomes
por: Rao, Yuan James, et al.
Publicado: (2017)

Proton Beam Therapy for Unresectable Mediastinal and Pericardial Spindle Cell Sarcoma: A Case Report
por: Laughlin, Brady S., et al.
Publicado: (2023)

Outcome for Children with Metastatic Solid Tumors over the Last Four Decades
por: Perkins, Stephanie M., et al.
Publicado: (2014)

Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small‐spot intensity‐modulated proton versus volumetric‐modulated arc therapies
por: Liu, Chenbin, et al.
Publicado: (2019)

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy
por: Youssef, Fady F., et al.
Publicado: (2016)

Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis
por: Badiyan, Shahed N, et al.
Publicado: (2013)

Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial
por: Choi, J. Isabelle, et al.
Publicado: (2022)

Proton Therapy of Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer: Acute Toxicity
por: Choo, Richard, et al.
Publicado: (2021)

Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience
por: Laughlin, Brady S., et al.
Publicado: (2022)

Impact of COVID 19 Pandemic on Radiation Oncology Care Path Time
por: Laughlin, B., et al.
Publicado: (2022)

Modelling small block aperture in an in-house developed GPU-accelerated Monte Carlo-based dose engine for pencil beam scanning proton therapy
por: Feng, Hongying, et al.
Publicado: (2023)

Long-term outcomes of follicular variant vs classic papillary thyroid carcinoma
por: Henke, Lauren E, et al.
Publicado: (2018)

Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience
por: Laughlin, Brady S., et al.
Publicado: (2023)

Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial
por: Henke, Lauren E., et al.
Publicado: (2018)

Beam mask and sliding window-facilitated deep learning-based accurate and efficient dose prediction for pencil beam scanning proton therapy
por: Zhang, Lian, et al.
Publicado: (2023)

Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
por: Markovina, Stephanie, et al.
Publicado: (2018)

Hormonal therapy in uterine sarcomas
por: Zang, Yuqin, et al.
Publicado: (2019)

Patterns of care and survival outcomes after treatment for uveal melanoma in the post-coms era (2004-2013): a surveillance, epidemiology, and end results analysis
por: Rao, Yuan James, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6tgal4h1262cd0vejd3gifm67h